Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)
Mesorectal Excision With Lateral Lymph Node Dissection Versus Without Lateral Lymph Node Dissection for Clinical Stage II, III Lower Rectal Cancer (JCOG0212)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Aichi
-
Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan, 464-8681
- Aichi Cancer Center Hospital
-
Toyoake,Kutsukake-cho,Dengakugakubo,1-98, Aichi, Japan, 470-1192
- Fujita Health University
-
-
Chiba
-
Chiba,Chuo-ku,Nitona-cho,666-2, Chiba, Japan, 260-8717
- Chiba Cancer Center Hospital
-
Kashiwa,Kashiwanoha,6-5-1, Chiba, Japan, 277-8577
- National Cancer Center Hospital East
-
Sakura,Shimoshidu,564-1, Chiba, Japan, 285-8741
- Toho University Sakura Hospital
-
Urayasu,Tomioka,2-1-1, Chiba, Japan, 279-0021
- Jyuntendo Urayasu Hospital
-
-
Ehime
-
Matsuyama,Horinouchi,13, Ehime, Japan, 790-0007
- National Hospital Organization Shikoku Cancer Center
-
-
Fukuoka
-
Fukuoka,Minami-ku,Notame,3-1-1, Fukuoka, Japan, 811-1395
- National Kyushu Cancer Center
-
Kurume,Asahi-machi,67, Fukuoka, Japan, 830-0011
- Kurume University School of Medicine
-
Kurume,Kokubumachi,155-1, Fukuoka, Japan, 839-0863
- Kurume University Medical Center
-
-
Gunma
-
Ota,Takabayashi-nishi-cho,617-1, Gunma, Japan, 373-8550
- Gunma Prefectural Cancer Center
-
-
Hiroshima
-
Hiroshima,Minami-ku,Kasumi,1-2-3, Hiroshima, Japan, 734-8551
- Hiroshima University, School of Medicine
-
Hiroshima,Naka-ku,Motomachi,7-33, Hiroshima, Japan, 730-8518
- Hiroshima City Hospital
-
-
Hokkaido
-
North-3,East8-5,Chuou-ku,Sapporo, Hokkaido, Japan, 060-0033
- Sapporo-Kosei General Hospital
-
-
Hyogo
-
Amagasaki,Inabasou,3-1-69, Hyogo, Japan, 660-8511
- Kansai Rosai Hospital
-
-
Ibaraki
-
Nishi-ibarakigun,Tomobemachi,Koibuchi,6528, Ibaraki, Japan, 309-1793
- Ibaraki Kenritsu Chuo Hospital & Cancer Center
-
-
Ishikawa
-
Kanazawa,Kuratsuki-Higashi,2-1, Ishikawa, Japan, 920-8530
- Ishikawa Prefectual Central Hospital
-
-
Kanagawa
-
Kawasaki,Takatsu-ku,Mizonokuchi,3-8-3, Kanagawa, Japan, 213-8507
- Teikyo University Hospital, Mizonokuchi
-
Sagamihara,Asamizodai,2-1-1, Kanagawa, Japan, 228-8520
- Kitasato University East Hospital
-
Sagamihara,Kitasato,1-15-1, Kanagawa, Japan, 228-8555
- Kitasato University School of Medichine
-
Yokohama,Asahi-ku,Nakao,1-1-2, Kanagawa, Japan, 241-0815
- Kanagawa Cancer Center
-
Yokohama,Minami-ku,Urafunecho,4-57, Kanagawa, Japan, 232-0024
- Yokohama City University Medical Center
-
Yokohama,Tsuzuki-ku,Chigasakichuo,35-1, Kanagawa, Japan, 224-8503
- Showa University Northern Yokohama Hospital
-
-
Kyoto
-
Kyoto,Fushimi-ku,Fukakusa,Mukaihata-cho,1-1, Kyoto, Japan, 612-8555
- National Hospital Organization Kyoto Medical Center
-
-
Miyagi
-
Natori,Medeshima-Shiode,Nodayama,47-1, Miyagi, Japan, 981-1293
- Miyagi Cancer Center
-
-
Nagano
-
Nagano,Tomitake,1333-1, Nagano, Japan, 381-8551
- Nagano Municipal Hospital
-
-
Niigata
-
Niigata,Kawagishi-cho,2-15-3, Niigata, Japan, 951-8566
- Niigata Cancer Center Hospital
-
-
Oita
-
Oita,Hasama-machi,Oogaoka,1-1, Oita, Japan, 879-5593
- Oita University Fuculty of Medicine
-
-
Okayama
-
Okayama,Ifukucho,1-17-18, Okayama, Japan, 700-8511
- Okayama Saiseikai General Hospital
-
-
Osaka
-
Minoh,Kayano,5-7-1, Osaka, Japan, 562-8562
- Minoh City Hospital
-
Osaka,Chuo-ku,Hoenzaka,2-1-14, Osaka, Japan, 540-0006
- Osaka National Hospital
-
Osaka,Higashinari-ku,Nakamichi,1-3-3, Osaka, Japan, 537-8511
- Osaka Medical Center for Cancer and Cardiovascular Diseases
-
Osaka,Miyakojima-ku,Miyakojimahondori,2-13-22, Osaka, Japan, 534-0021
- Osaka City General Hospital
-
Sakai,Minamiyasuicho,1-1-1, Osaka, Japan, 590-0064
- Sakai Municipal Hospital
-
Suita,Yamada-oka,2-2, Osaka, Japan, 565-0871
- Osaka University Graduate School of Medicine
-
Takatsuki,Daigakucho,2-7, Osaka, Japan, 569-0801
- Osaka Medical College
-
-
Saitama
-
Saitama,Omiya-ku,Amanuma-cho,1-847, Saitama, Japan, 330-8503
- Omiya Medical Center, Jichi Medical School
-
Tokorozawa,Namiki,3-2, Saitama, Japan, 359-8513
- National Defense Medical College
-
-
Shizuoka
-
Sunto-gun,Nagaizumi-cho,Shimonagakubo,1007, Shizuoka, Japan, 411-8777
- Sizuoka Cancer Center
-
-
Tochigi
-
Utsunomiya,Yohnan,4-9-13, Tochigi, Japan, 320-0834
- Tochigi Cancer Center
-
-
Tokyo
-
Bunkyo-ku,Yushima,1-5-45, Tokyo, Japan, 113-8519
- Tokyo Medical and Dental University Hospital
-
Chuo-ku,Tsukiji, 5-1-1, Tokyo, Japan, 104-0045
- National Cancer Center Hospital
-
Meguro-ku,Ohashi,2-17-6, Tokyo, Japan, 153-0044
- Toho University Ohashi Hospital
-
Minato-ku,Toranomon,2-2-2, Tokyo, Japan, 105-8470
- Toranomon Hospital
-
Mitaka,Shinkawa,6-20-2, Tokyo, Japan, 181-8611
- Kyorin University School of Medicine
-
Shinjuku-ku,Nishi-shinjuku,6-7-1, Tokyo, Japan, 160-0023
- Tokyo Medical University
-
Shinjuku-ku,Shinanomachi,35, Tokyo, Japan, 160-8582
- Keio University Hospital
-
-
Yamagata
-
Yamagata,Aoyagi,1800, Yamagata, Japan, 990-2292
- Yamagata Prefectural Central Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Preoperative criteria:
- Histologically confirmed adenocarcinoma
- Clinical stage II or III
Preoperative findings:
- Main lesion of the tumor is located at the rectum
- Lower tumor margin is below the peritoneal reflection
- No extramesorectal lymph node swelling (Shorter diameter is less than 10 mm)
- No invasion to other organ (s)
- Patient age is more than 20 and less than 75
- PS: 0, 1
- No past history of chemotherapy, pelvic surgery or radiation
Written informed consent
Operative criteria:
- Mesorectal excision is performed
Operative findings:
- Main lesion of the tumor is located at the rectum
- Lower tumor margin is below the peritoneal reflection
- R0 after resection
Exclusion Criteria:
- Multiple cancer patients
- Pregnant patients
- Psychological disorder
- Steroid administration
- Cardiac infarction within six months
- Severe pulmonary emphysema and pulmonary fibrosis
- Doctor's decision for exclusion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 1
Procedure/Surgery: Mesorectal excision with lateral lymph node dissection
|
Mesorectal excision with lateral lymph node dissection
|
|
Experimental: 2
Procedure/Surgery: Mesorectal excision without lateral lymph node excision
|
Mesorectal excision without lateral lymph node excision
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Relapse-free survival
Time Frame: Until relapsing
|
Until relapsing
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of adverse events
Time Frame: 5 years
|
5 years
|
|
Overall survival
Time Frame: Overall
|
Overall
|
|
Local-recurrence-free survival
Time Frame: Until local-recurrence
|
Until local-recurrence
|
|
Incidence of major adverse events
Time Frame: 5 years
|
5 years
|
|
Operative time
Time Frame: Operation day
|
Operation day
|
|
Blood loss
Time Frame: Operation day
|
Operation day
|
|
Incidence of sexual and urinary dysfunction
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Chair: Shin Fujita, MD, National Cancer Center Hospital
Publications and helpful links
General Publications
- Tsukamoto S, Fujita S, Ota M, Mizusawa J, Shida D, Kanemitsu Y, Ito M, Shiomi A, Komori K, Ohue M, Akazai Y, Shiozawa M, Yamaguchi T, Bando H, Tsuchida A, Okamura S, Akagi Y, Takiguchi N, Saida Y, Akasu T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Br J Surg. 2020 Apr;107(5):586-594. doi: 10.1002/bjs.11513. Epub 2020 Mar 12.
- Saito S, Fujita S, Mizusawa J, Kanemitsu Y, Saito N, Kinugasa Y, Akazai Y, Ota M, Ohue M, Komori K, Shiozawa M, Yamaguchi T, Akasu T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. Eur J Surg Oncol. 2016 Dec;42(12):1851-1858. doi: 10.1016/j.ejso.2016.07.010. Epub 2016 Jul 30.
- Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T, Moriya Y; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 2012 Jun;13(6):616-21. doi: 10.1016/S1470-2045(12)70158-4. Epub 2012 May 15.
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- JCOG0212
- C000000034 (Registry Identifier: UMIN-CTR)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.